Discrimination Between Myocardial and Skeletal Muscle Injury by Assessment of the Plasma Ratio of Myoglobin Over Fatty Acid–Binding Protein
- 15 November 1995
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 92 (10), 2848-2854
- https://doi.org/10.1161/01.cir.92.10.2848
Abstract
Background Myoglobin and fatty acid–binding protein (FABP) each are useful as early biochemical markers of muscle injury. We studied whether the ratio of myoglobin over FABP in plasma can be used to distinguish myocardial from skeletal muscle injury. Methods and Results Myoglobin and FABP were assayed immunochemically in tissue samples of human heart and skeletal muscle and in serial plasma samples from 22 patients with acute myocardial infarction (AMI), from 9 patients undergoing aortic surgery (causing injury of skeletal muscles), and from 10 patients undergoing cardiac surgery. In human heart tissue, the myoglobin/FABP ratio was 4.5 and in skeletal muscles varied from 21 to 73. After AMI, the plasma concentrations of both proteins were elevated between ≈1 and 15 to 20 hours after the onset of symptoms. In this period, the myoglobin/FABP ratio was constant both in subgroups of patients receiving and those not receiving thrombolytics and amounted to 5.3±1.2 (SD). In serum from aortic surgery patients, both proteins were elevated between 6 and 24 hours after surgery; the myoglobin/FABP ratio was 45±22 (SD), which is significantly different from plasma values in AMI patients ( P <.001). In patients with cardiac surgery, the ratio increased from 11.3±4.7 to 32.1±13.6 (SD) during 24 hours after surgery, indicating more rapid release of protein from injured myocardium than from skeletal muscles. Conclusions The ratio of the concentrations of myoglobin over FABP in plasma from patients with muscle injury reflects the ratio found in the affected tissue. Since this ratio is different between heart (4.5) and skeletal muscle (20 to 70), its assessment in plasma allows the discrimination between myocardial and skeletal muscle injury in humans.This publication has 19 references indexed in Scilit:
- Cytoplasmic fatty acid-binding proteins: Their structure and genesProgress in Lipid Research, 1995
- Monoclonal antibodies to human heart fatty acid-binding proteinJournal of Immunological Methods, 1995
- Fatty-acid-binding protein as a plasma marker for the estimation of myocardial infarct size in humans.Heart, 1994
- Human heart-type cytoplasmic fatty acid-binding protein in serum and urine during hyperacute myocardial infarctionInternational Journal of Cardiology, 1993
- Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in manMolecular and Cellular Biochemistry, 1992
- Serum and urinary human heart fatty acid-binding protein in acute myocardial infarctionClinical Biochemistry, 1991
- Subcellular distribution of cardiac fatty acid-binding protein in bovine heart muscle and quantitation with an enzyme-linked immunosorbent assayBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
- Enzymatic assessment of myocardial necrosis after cardiac surgery: Differentiation from skeletal muscle damage, hemolysis, and liver injuryAmerican Heart Journal, 1985
- Myoglobin content in human skeletal muscle and myocardium: relation to fibre size and oxidative capacityCardiovascular Research, 1984
- Serum myoglobin level as diagnostic test in patients with acute myocardial infarction.Heart, 1977